CERVANTES: an international randomized trial of radical surgery followed by adjuvant (chemo) radiation versus no further treatment in patients with early-stage, intermediate-risk cervical cancer (CEEGOG-CX-05; ENGOT-CX16)David Cibula, Martina Borčinová, Roman Kocian, David Feltl, Sona Argalacsova, Pavel Dvorak, Daniela Fischerová, Pavel Dundr, Jiri Jarkovsky, Eva Höschlová, Jiri Slama, Giovanni Scambia
13 September 2022
Incidence of lymph node metastasis in early-stage low-grade serous ovarian cancer: a systematic reviewDavid Viveros-Carreño, Juliana Rodriguez, Rene Pareja
13 July 2022
Adjuvant treatment after radical surgery for cervical cancer with intermediate risk factors: is it time for an update?Juliana Rodriguez, David Viveros-Carreño, Rene Pareja
6 September 2022
Adjuvant chemotherapy for stage I high-intermediate risk endometrial carcinoma with lymph-vascular invasionDimitrios Nasioudis, Jinhee Oh, Emily M Ko, Ashley F Haggerty, Lori Cory, Robert L Giuntoli II, Sarah H Kim, Mark A Morgan, Nawar A Latif
1 June 2022
Demographic shifts associated with implementation of evidence-based guidelines for ovarian conservation in patients with endometrioid endometrial cancerBeryl L Manning-Geist, Eric Rios-Doria, Emeline M Aviki, Qin Zhou, Alexia Iasonos, Nadeem R Abu-Rustum, Carol L Brown, Jennifer J Mueller
13 July 2022
ATOMICC trial: a randomized, open-label, phase II trial of anti-PD1, dostarlimab, as maintenance therapy for patients with high-risk locally advanced cervical cancer after chemoradiationCarmen Garcia-Duran, Francisco Grau, Guillermo Villacampa, Ana Oaknin
20 April 2022
Endometrial stripe thickness: a preoperative marker to identify patients with endometrial intraepithelial neoplasia who may benefit from sentinel lymph node mapping and biopsyDevon Abt, Annliz Macharia, Michele R Hacker, Rasha Baig, Katharine McKinley Esselen, Jennifer Ducie
22 July 2022
Safety and efficacy of an outpatient 12-step desensitization protocol for antineoplastic agentsIdil Eroglu, Olga T Filippova, Maria Kirrane, Mary Orpen, Vianca Almonte, Rachel Thomas, Melissa Lee-Teh, Richard Tizon, Nancy Sklarin, Roisin O’Cearbhaill
8 June 2022
CHRONO: randomized trial of the CHROnology of surgery after Neoadjuvant chemotherapy for Ovarian cancerJean-Marc Classe, Gwennael Ferron, Lobna Ouldamer, Tristan Gauthier, Sheik Emambux, Laurence Gladieff, Pierre-Francois Dupre, Amélie Anota
23 March 2022
Survival impact of histological response to neoadjuvant chemotherapy according to number of cycles in patients with advanced ovarian cancerSarah Betrian, Martina Aida Angeles, Antonio Gil Moreno, Bastien Cabarrou, Marion Deslandres, Gwenael Ferron, Eliane Mery, Anne Floquet, Frederic Guyon, Assumpció Pérez-Benavente, Emanuela Spagnolo, Agnieszka Rychlik, Laurence Gladieff, Alicia Hernández Gutiérrez, Alejandra Martinez
20 July 2022